An experimental Alzheimer's treatment from Boston researchers may be able to treat both dementia and depression symptoms.

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

THURSDAY, March 20, 2025 (HealthDay News) -- Dancing is known to lift the spirit, and a new study shows that Alzheimer’s ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Discover how intermittent fasting can help improve sleep, memory, and cognitive function in Alzheimer's patients by ...

New research warns that blood tests for Alzheimer’s disease may be unreliable, particularly for Black patients. A recent ...

The modest benefits mean some doctors and patients to shy away from using them. Researchers testing gantenerumab in people with gene mutations that set them up for Alzheimer’s in the DIAN got ...

Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...